Element Biosciences Closes $276 Million Series C Financing to Democratize Access to Genomics

Retrieved on: 2021-06-29 12:56:15

Tags for this article:

Click the tags to see associated articles and topics

Element Biosciences Closes $276 Million Series C Financing to Democratize Access to Genomics. View article details on hiswai:

Excerpt

New investors Janus Henderson Investors, Logos Capital, Meritech Capital Partners, Counterpoint Global (Morgan Stanley), and T. Rowe Price joined ...

Article found on: www.prnewswire.com